Cargando…
Retracted: Clinical Efficacy of Ulinastatin Combined with Meglumine Adenosine Cyclophosphate in the Treatment of Acute Myocardial Infarction
Autor principal: | Methods in Medicine, Computational and Mathematical |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9711947/ https://www.ncbi.nlm.nih.gov/pubmed/36466556 http://dx.doi.org/10.1155/2022/9793601 |
Ejemplares similares
-
Clinical Efficacy of Ulinastatin Combined with Meglumine Adenosine Cyclophosphate in the Treatment of Acute Myocardial Infarction
por: Zhang, Zhenying, et al.
Publicado: (2022) -
Retracted: The Efficacy and Safety of Bisoprolol in the Treatment of Myocardial Infarction with Cardiac Insufficiency
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023) -
Retracted: Clinical Nursing Pathway Improves Therapeutic Efficacy and Quality of Life of Elderly Patients with Acute Myocardial Infarction
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023) -
Retracted: Effects of Ulinastatin on Myocardial Ischemia-Reperfusion Injury, Cardiac Function, and Serum TNF-α and IL-10 Levels in Patients Undergoing Cardiac Valve Replacement under Cardiopulmonary Bypass
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023) -
Retracted: Effects of Dapagliflozin in Combination with Metoprolol Sustained-Release Tablets on Prognosis and Cardiac Function in Patients with Acute Myocardial Infarction after PCI
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)